A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration

van Asten Freekje; Evers-Birkenkamp Kim U.; van Lith-Verhoeven Janneke J. C.; de Jong-Hesse Yvonne; Hoppenreijs Vincent P. T.; Hommersom Richard F.; Scholten Agnes M.; Hoyng Carel B.; Klaver Johannes H. J.

首页> 外文期刊>Acta ophthalmologica >A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration

【24h】

A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration

机译：前瞻性，开放性，开放性，多中心研究，研究了兰尼单抗在新血管性年龄相关性黄斑变性患者中的日常治疗方法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeThe HELIOS (Health Economics with Lucentis in Observational Settings) study was designed on request of the Dutch Health Authority for an observational study to assess the effectiveness and safety of ranibizumab for neovascular age-related macular degeneration (wet AMD) in daily practice.

机译：目的HELIOS（观察性环境中具有Lucentis的健康经济学）研究是应荷兰卫生局的要求而设计的一项观察性研究，旨在评估兰尼单抗在日常实践中对新生血管性年龄相关性黄斑变性（湿性AMD）的有效性和安全性。

著录项

来源
《Acta ophthalmologica》 |2015年第2期|共8页
作者
van Asten Freekje; Evers-Birkenkamp Kim U.; van Lith-Verhoeven Janneke J. C.; de Jong-Hesse Yvonne; Hoppenreijs Vincent P. T.; Hommersom Richard F.; Scholten Agnes M.; Hoyng Carel B.; Klaver Johannes H. J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
daily practice; neovascular AMD; observational; quality of life; ranibizumab; visual acuity;

机译：日常操作;血管性AMD;观察;生活质量;拉尼单抗;视力;
入库时间 2022-08-18 09:50:10

相似文献

外文文献
中文文献
专利

1. A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration [J] . van Asten Freekje, Evers-Birkenkamp Kim U., van Lith-Verhoeven Janneke J. C., Acta ophthalmologica . 2015,第2期

机译：前瞻性，开放性，开放性，多中心研究，研究了兰尼单抗在新血管性年龄相关性黄斑变性患者中的日常治疗方法
2. One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study [J] . LarsHjelmqvist, CharlotteLindberg, P?rKanulf, Journal of Ophthalmology . 2011,第3期

机译：使用雷珠单抗治疗新生血管性年龄相关性黄斑变性的一年结局：一项前瞻性和回顾性观察性多中心研究的结果
3. Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration [J] . Elman Michael J., Brown David M., Kaiser Peter K., Investigative ophthalmology & visual science . 2018,第9期

机译：与Ranibizimab双药草的治疗幼鱼乳蛋白单疗法与Ranibizimab与ranibizimab与Ranibizimab单疗法相比，与Ranibizimab的单一治疗与Ranibizimab双胍溶解的临床研究与Ranibizimab Ophthalmic溶液相比，与Ranibizimab的治疗中的治疗中的幼苗单一治疗相比，临床研究与Ranibizimizumab相比。退化
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Characterizing response patterns to ranibizumab therapy in patients with wet age-related macular degeneration: A latent class growth analysis [D] . Sun, Diana 2015

机译：潮湿年龄相关性黄斑变性患者的ranibizumab治疗的表征反应模式：潜在的增长分析
6. A 2-Year Phase IV Multicentre Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study [O] . Sergio Pagliarini, Stephen Beatty, Blandina Lipkova, 2014

机译：常规临床实践中Ranibizumab0.5μmg在与新生血管性年龄相关的黄斑变性患者中进行的为期2年IV期多中心的观察性研究：EPICOHORT研究
7. A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration [O] . van Asten, Freekje, Evers-Birkenkamp, Kim U., van Lith-Verhoeven, Janneke J. C., 2015

机译：前瞻性，开放性，开放性，多中心研究，研究了兰尼单抗在新生血管性年龄相关性黄斑变性患者中的日常治疗方法

A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration

摘要

著录项

相似文献

相关主题

期刊订阅